Table 3.
Study | Interventions | Response rates
|
|||
---|---|---|---|---|---|
Odds ratios | 95% confidence intervals | P-values | Z-score | ||
Mahableshwarkar et al16 | T: vortioxetine 2.5 mg/d | 1.16 | (0.84, 1.60) | 0.38 | 0.89 |
Mahableshwarkar et al15 | C: placebo | ||||
Mahableshwarkar et al16 | T: vortioxetine 5 mg/d | 1.41 | (0.82, 2.41) | 0.21 | 1.25 |
Bidzan et al18 | C: placebo | ||||
Rothschild et al17 | |||||
Mahableshwarkar et al16 | T: vortioxetine 10 mg/d | 1.05 | (0.76, 1.46) | 0.75 | 0.32 |
Mahableshwarkar et al15 | C: placebo | ||||
Mahableshwarkar et al16 | T: vortioxetine 2.5 mg/d | 1.10 | (0.80, 1.52) | 0.57 | 0.57 |
Mahableshwarkar et al15 | C: vortioxetine 10 mg/d |
Abbreviations: GAD, generalized anxiety disorder; RCT, randomized control trial; T, treatment group; C, control group.